Clinical Trial Update: Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial evaluates a polyphenol-rich beverage derived from red grape pomace for its effects on nonalcoholic fatty liver disease, cardiometabolic risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Red grape pomace polyphenol beverage

Snippet

Sponsor: Federico II University | Conditions: Diabetes Mellitus Type 2 | NA | Status: ENROLLING_BY_INVITATION